SuperworthGenprex EPS GNPX
Diluted earnings per share by quarter and over the last twelve months, from 2016.
- Last 12 months, to Dec 31, 2021
- −$18040.00
- Latest quarter, Q4 FY21
- −$5280.00
- Fiscal year 2021
- −$18040.00
Genprex's earnings per share was −$18040.00 over the twelve months to Dec 31, 2021.
In its latest quarter, Q4 FY21, it was −$5280.00.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2021 | −$18040.00 | n/a |
| FY2020 | −$22880.00 | n/a |
| FY2019 | −$29480.00 | n/a |
| FY2018 | −$39160.00 | n/a |
| FY2017 | −$12760.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY21 | −$5280.00 | n/a | −$18040.00 | |
| Q3 FY21 | −$3080.00 | n/a | −$18480.00 | |
| Q2 FY21 | −$3520.00 | n/a | −$18480.00 | |
| Q1 FY21 | −$6160.00 | n/a | −$20240.00 | |
| Q4 FY20 | −$5720.00 | n/a | −$22880.00 | |
| Q3 FY20 | −$3080.00 | n/a | −$23320.00 | |
| Q2 FY20 | −$5280.00 | n/a | −$26840.00 | |
| Q1 FY20 | −$8800.00 | n/a | −$32120.00 | |
| Q4 FY19 | −$6160.00 | n/a | −$29480.00 | |
| Q3 FY19 | −$6600.00 | n/a | −$33440.00 | |
| Q2 FY19 | −$10560.00 | n/a | −$33440.00 | |
| Q1 FY19 | −$6160.00 | n/a | −$42680.00 |
Against its peers
Companies in Healthcare nearest Genprex's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| GNPXGenprex | n/m | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| Peer median | $0.19 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Genprex
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.